NCT06822530View on ClinicalTrials.gov

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

682

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

November 30, 2029

Conditions
Colorectal Carcinoma
Interventions
OTHER

Best Practice

Receive usual care CRC screening program navigation

OTHER

Educational Intervention

Receive QR code and link to video addressing fears of colonoscopy

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Interview

Ancillary studies

OTHER

Supportive Care

Receive rideshare transportation home after colonoscopy

OTHER

Survey Administration

Ancillary studies

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT06822530 - A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial | Biotech Hunter | Biotech Hunter